SIRT1 regulates metabolism and leukemogenic potential in CML stem cells-Reference-Cited by-同舟云学术

SIRT1 regulates metabolism and leukemogenic potential in CML stem cells

Published:2019-06-10 Issue:7 Volume:129 Page:2685-2701
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Abraham Ajay,Qiu Shaowei,Chacko Balu K.^ORCID,Li Hui,Paterson Andrew,He Jianbo,Agarwal Puneet,Shah Mansi,Welner Robert,Darley-Usmar Victor M.,Bhatia Ravi

Funder

NIH Office of the Director

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/127080/files/pdf

Reference51 articles.

1. Imatinib and beyond—exploring the full potential of targeted therapy for CML

2. Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment

3. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

4. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

5. Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammation;International Journal of Biological Macromolecules;2024-10

2. Interplay between epigenetics and metabolism controls cancer stem cell plasticity;Frontiers in Epigenetics and Epigenomics;2024-09-11

3. Novel targeted therapies in chronic myeloid leukemia;Pharmaceutical Science Advances;2024-09

4. Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia;Science Translational Medicine;2024-06-12

5. Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications;Frontiers in Bioengineering and Biotechnology;2024-05-23